Friday, February 22, 2019

Gadolinium-Based Contrast Agents utilized during MRIs have been linked gadolinium toxicity, Gadolinium Deposition Disease, and Nephrogenic Systemic Fibrosis.

Below are the news stories and videos we have posted on this topic, including the details of the lawsuits that have been filed.

Gadolinium News

What Patients Should Know About Gadolinium-based Contrast Agents

Gadolinium-based contrast agents (GABAs) were first approved by the FDA in 1998. The American College of Radiology estimates that over the past two decades GABAs have been used on 300 million people around the globe in order to assist doctors in interpreting MRIs. According to a recent article in...

Iron-Based Contrast Agent in MRIs is 100% More Effective Than Gadolinium – and Far Less Toxic

A group of scientists at Rice University has devised a way to use iron in MRI contrast agents that are less toxic than gadolinium – and work twice as well.The process, described in a recent report published in ACS Nano, involves the insertion of ferrous molecules into nanoparticles known...

Toxic MRI Gadolinium-Based Contrast Agent Causing Debilitating Diseases In Patients

Each year in the United States, more than 10% of the population will undergo an MRI scan, and a good portion of those will include the use of a contrast agent that contains the element gadolinium. This element can be highly toxic to human beings, and it has now...
Gadolinium Videos